Atlas Trials

Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex

Clinical trial NCT02212587 · COMPLETED

Trial details

NCT number
NCT02212587
Sponsor
Unity Health Toronto
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic FibrosisBurkholderia Cepacia Infection
Start date
2014-09-01
Primary completion
2016-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.